Skip to main content

Advertisement

Fig. 4 | Cellular & Molecular Biology Letters

Fig. 4

From: MiR-106a directly targets LIMK1 to inhibit proliferation and EMT of oral carcinoma cells

Fig. 4

The effects of miR-106a on proliferation and related molecules in OSCC cells. SCC4 cells were transfected with the miR-106a mimic or inhibitor for 48 h. a The level of miR-106a was detected via quantitative RT-PCR. b Cell proliferation was assessed with a BrdU-ELISA assay. c The mRNA expressions of PCNA, CDK2, CDK4, cyclin D1, cyclin E1, p21 and p27 were determined via quantitative RT-PCR. All data are presented as means ± SEM, n = 6. #p < 0.05, ##p < 0.01, ###p < 0.001 vs. miR-NC or anti-miR-NC

Back to article page